Medicare Enrolled

Dr. Lawrence Davanzo, D.O.

Critical Care Medicine · Somerset, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
49 VERONICA AVE, Somerset, NJ 08873
7322463066
In practice since 2006 (20 years)
NPI: 1902834708 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Davanzo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Davanzo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Davanzo

Dr. Lawrence Davanzo is a critical care medicine specialist in Somerset, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Davanzo performed 2,397 Medicare services across 1,016 unique beneficiaries.

Between the years covered by Open Payments, Dr. Davanzo received a total of $21,687 from 48 pharmaceutical and/or device companies across 1234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Davanzo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in NJ $21,687 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,397
Medicare services
Top 18% in NJ for critical care medicine
1,016
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~120 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
533 $105 $363
Outpatient pulmonary rehabilitation session
A professional service session for pulmonary rehabilitation provided in an outpatient setting. This code covers the clinical services delivered during a single session.
457 $54 $165
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
457 $105 $321
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function.
174 $134 $660
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
141 $75 $218
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
133 $70 $254
Inhalation treatment for airway obstruction or sputum production
A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production.
73 $8 $72
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
72 $16 $66
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
61 $34 $148
Exercise stress test
A test that monitors the heart and lungs while the patient exercises to evaluate their function under physical stress.
55 $130 $608
Positive pressure ventilator therapy
A therapy procedure that uses a positive pressure ventilator to assist with breathing.
44 $55 $235
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
43 $87 $322
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
40 $138 $487
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
33 $30 $123
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
25 $35 $228
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
25 $159 $706
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
19 $17 $52
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
12 $25 $135
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,687
Total received (2018-2024)
Avg $3,098/year across 7 years
Top 6% in NJ for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,234
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,218 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$469 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,559
2023
$4,333
2022
$3,237
2021
$2,752
2020
$2,603
2019
$2,350
2018
$1,854

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,434
GlaxoSmithKline, LLC.
$610
Avadel CNS Pharmaceuticals, LLC
$576
JAZZ PHARMACEUTICALS INC.
$434
Boehringer Ingelheim Pharmaceuticals, Inc.
$270
GENZYME CORPORATION
$165
Axsome Therapeutics, Inc.
$160
Mylan Specialty L.P.
$146
SANOFI-AVENTIS U.S. LLC
$95
Merck Sharp & Dohme LLC
$85
Actelion Pharmaceuticals US, Inc.
$80
Amgen Inc.
$66
United Therapeutics Corporation
$64
Electromed, Inc.
$53
Azurity Pharmaceuticals, Inc.
$51
Bayer Healthcare Pharmaceuticals Inc.
$48
Harmony Biosciences Llc
$46
Inspire Medical Systems, Inc.
$38
Regeneron Healthcare Solutions, Inc.
$35
HARMONY BIOSCIENCES LLC
$34
Baxter Healthcare
$20
Takeda Pharmaceuticals U.S.A., Inc.
$17
Insmed, Inc.
$16
Mallinckrodt Hospital Products Inc.
$16
Top 3 companies account for 57.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,673
GlaxoSmithKline, LLC.
$4,338
Actelion Pharmaceuticals US, Inc.
$1,706
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,663
JAZZ PHARMACEUTICALS INC.
$940
Mylan Specialty L.P.
$911
GENZYME CORPORATION
$893
Jazz Pharmaceuticals Inc.
$661
Avadel CNS Pharmaceuticals, LLC
$611
Harmony Biosciences LLC
$451
Axsome Therapeutics, Inc.
$423
Amgen Inc.
$356
Genentech USA, Inc.
$347
Grifols USA, LLC
$299
United Therapeutics Corporation
$253
Bayer HealthCare Pharmaceuticals Inc.
$246
Merck Sharp & Dohme LLC
$231
Insmed, Inc.
$228
Regeneron Healthcare Solutions, Inc.
$206
SANOFI-AVENTIS U.S. LLC
$195
Gilead Sciences, Inc.
$172
Philips Electronics North America Corporation
$163
Circassia Pharmaceuticals Inc
$154
Mallinckrodt Hospital Products Inc.
$147
Takeda Pharmaceuticals U.S.A., Inc.
$134
Vanda Pharmaceuticals Inc.
$115
Mallinckrodt LLC
$111
Merck Sharp & Dohme Corporation
$107
HARMONY BIOSCIENCES LLC
$106
Inspire Medical Systems, Inc.
$101
Bayer Healthcare Pharmaceuticals Inc.
$95
Novartis Pharmaceuticals Corporation
$73
Teva Pharmaceuticals USA, Inc.
$68
Baxter Healthcare
$68
Electromed, Inc.
$67
Inogen, Inc.
$52
Azurity Pharmaceuticals, Inc.
$51
Harmony Biosciences Llc
$46
Shire North American Group Inc
$42
IDORSIA PHARMACEUTICALS US INC
$29
Paratek Pharmaceuticals, Inc.
$28
Mallinckrodt Enterprises LLC
$26
Pulmonx Corporation
$24
Itamar Medical Inc
$22
NOVARTIS PHARMACEUTICALS CORPORATION
$16
Resmed Corp
$15
ARBOR PHARMACEUTICALS, INC.
$13
Pernix Therapeutics Holdings, Inc.
$13
Top 3 companies account for 49.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Adempas · AirDuo Digihaler · AirSense · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · COMBIVENT RESPIMAT · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · Esbriet · FARXIGA · FASENRA · GLASSIA · HETLIOZ · HORIZANT · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Horizant · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · JANUVIA · LUMRYZ · NIOX VERO · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · SILENOR · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · UPTRAVI · WAKIX · WINREVAIR · Wakix · WatchPATONE · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for critical care medicine in NJ.

Looking for a critical care medicine specialist in Somerset?
Compare critical care medicines in the Somerset area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical care medicines within 10 mi
89
Per 100K population
25.7
County median income
$135,960
Nearest hospital
UNIVERSITY BEHAVIORAL HEALTH CARE
4.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Davanzo is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NJ), with low-engagement industry engagement in the top 6% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Davanzo experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Davanzo performed 533 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Davanzo receive payments from pharmaceutical companies?
Yes. Dr. Davanzo received a total of $21,687 from 48 companies across 1,234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Davanzo's costs compare to other critical care medicines in Somerset?
Dr. Davanzo's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Davanzo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →